Two of Moderna’s mRNA-based HIV vaccines could start human trials this week, according to a new posting in the National Institutes of Health’s clinical trial registry. The Phase I study would test the vaccines’ safety, as well as collect basic data on whether they’re inducing any kind of immunity, but would still need to go through Phases II and III to see how effective they might be.
The White House has announced it is supporting waiving intellectual property protections for COVID-19 vaccines in an effort to expand access to vaccines worldwide.
You’ve probably heard of dry ice before — or maybe even made someyourself. But lately, dry ice has become a focal point in the news, due to its unique ability to help keep things very cold in transit without the same melted mess as regular ice. The Pfizer COVID-19 vaccine must be stored at a temperature of -94 degrees Fahrenheit (-70 degrees Celsius), and dry ice will play a crucial role in maintaining the correct temperature as the vaccine travels for distribution. In the United States, there are currently 14.8 million reported cases of COVID-19 and over 282,000 deaths, with the numbers expected to continue to climb during the holiday season amid record-high hospitalizations.
Only about half of Americans say that they’d like to get vaccinated for the new coronavirus if or when a vaccine becomes available, according to a new poll from the Associated Press and the NORC Center for Public Affairs Research. The poll, which was conducted between May 14-18, is a troubling sign that Americans may not be able to achieve herd immunity through vaccination. Continue reading Only Half of Americans Say They’ll Get Vaccinated for Covid-19, According to New Poll